TY - JOUR
T1 - Seventh BHD international symposium
T2 - recent scientific and clinical advancement
AU - Woodford, Mark R.
AU - Andreou, Avgi
AU - Baba, Masaya
AU - van de Beek, Irma
AU - Malta, Chiara Di
AU - Glykofridis, Iris
AU - Grimes, Hannah
AU - Henske, Elizabeth P.
AU - Iliopoulos, Othon
AU - Kurihara, Masatoshi
AU - Lazor, Romain
AU - Linehan, W. Marston
AU - Matsumoto, Kenki
AU - Marciniak, Stefan J.
AU - Namba, Yukiko
AU - Pause, Arnim
AU - Rajan, Neil
AU - Ray, Anindita
AU - Schmidt, Laura S.
AU - Shi, Wei
AU - Steinlein, Ortrud K.
AU - Thierauf, Julia
AU - Zoncu, Roberto
AU - Webb, Anna
AU - Mollapour, Mehdi
N1 - Funding Information: We would like to thank the Department of Urology, and Information Management & Technology Rachael A. Kim at SUNY Upstate Medical University for supporting this meeting. We are grateful to Sarah J. Backe for her constructive comments. This work presented at the meeting was supported by Cancer Research UK Cambridge Cancer Centre (A.A., & Eamonn R Maher); JSPS KAKENHI Grant Numbers JP22122002, JP 25713059, JP 15K15089, JP 18H05042, JP 18K19553, JP 17K15625, JP 18K16997, JP 18H02938 and JP 18K19619. (M.B.); European Research Council H2020 AdG LYSOSOMICS 694282’; Associazione Italiana per la Ricerca sul Cancro A.I.R.C.‘IG-22103. Worldwide Cancer Research grant 21-0278; 2020 KCA Young Investigator Award (YIA) Grant (C.D.); Cancer Center Amsterdam grant number CCA2018-5-51 (I.G and Rob M.F. Wolthuis); Canadian Institutes of Health Research (CIHR) (PJT-165829 and PJT-247494) and the Cancer Research Society (CRS) (79664), (A.P.). Terry Fox New Frontiers Program Project Grant (TFRI-251427), (A.P.); Newcastle NIHR Biomedical Research Centre (BRC), (N.R.); Federal funds from the Frederick National Laboratory for Cancer Research, NIH, under Contract HHSN261200800001E (L.S.S.); SUNY Upstate Medical University, Upstate Cancer Center and the Upstate Foundation (M.M.), the National Institute of General Medical Sciences of the National Institutes of Health under Award Number, R35GM139584 (M.M.), and R01GM124256 (M.M.). Publisher Copyright: © 2022 Impact Journals LLC. All rights reserved.
PY - 2022
Y1 - 2022
N2 - The 7th Birt-Hogg-Dubé (BHD) International Symposium convened virtually in October 2021. The meeting attracted more than 200 participants internationally and highlighted recent findings in a variety of areas, including genetic insight and molecular understanding of BHD syndrome, structure and function of the tumor suppressor Folliculin (FLCN), therapeutic and clinical advances as well as patients’ experiences living with this malady.
AB - The 7th Birt-Hogg-Dubé (BHD) International Symposium convened virtually in October 2021. The meeting attracted more than 200 participants internationally and highlighted recent findings in a variety of areas, including genetic insight and molecular understanding of BHD syndrome, structure and function of the tumor suppressor Folliculin (FLCN), therapeutic and clinical advances as well as patients’ experiences living with this malady.
UR - http://www.scopus.com/inward/record.url?scp=85125441152&partnerID=8YFLogxK
U2 - https://doi.org/10.18632/ONCOTARGET.28176
DO - https://doi.org/10.18632/ONCOTARGET.28176
M3 - Article
C2 - 35070081
SN - 1949-2553
VL - 13
SP - 173
EP - 181
JO - Oncotarget
JF - Oncotarget
IS - 1
ER -